Last reviewed · How we verify
NCT03966573
Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints
NA trial testing Radiographic imaging in Leg Length Inequality in 10 participants. Completed in 11 October 2019.
11 October 2019
Quick facts
| Lead sponsor | Oslo University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 10 |
| Start date | 6 March 2019 |
| Primary completion | 11 October 2019 |
| Estimated completion | 11 October 2019 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Radiographic imaging
- Evaluating function
- Forms
Conditions studied
- Leg Length Inequality — all drugs for Leg Length Inequality →
- Leg; Lengthening — all drugs for Leg; Lengthening →
- Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →
- Osteoarthritis of Hip — all drugs for Osteoarthritis of Hip →
Sponsor
Oslo University Hospital
Who can join
Eligibility, any sex, with Leg Length Inequality or Leg; Lengthening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates function, quality of life and development of hip- and knee osteoarthritis minimum 15 years after unilateral femoral lengthening on people with idiopathic or post-traumatic anisomelia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Femoral lengthening might impair physical function and lead to structural changes in adjacent joints: 10 patients with 27 to 34 years' follow-up.
Bjørge PA, Tveter AT, Steen H, Gunderson R, et al · · 2021 · PMID 33410356 · DOI 10.1080/17453674.2020.1866864
Verify or expand the search:
- PubMed search for NCT03966573
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Radiographic imaging
Trials testing the same drug.
- NCT07340853 — CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma · Phase 1 · recruiting
Other recruiting trials for Leg Length Inequality
Currently open trials in the same condition.
- NCT06156384 — Study to Assess the Pain, Satisfaction, and Quality of Life of Patients With FITBONE® Lengthening Nail · recruiting
Other Oslo University Hospital trials
Trials by the same sponsor.
- NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
- NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
- NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
- NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
- NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03966573 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
- Last refreshed: 26 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03966573.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing